Methylprednisolone therapy for retinal laser injury
- PMID: 10548120
- DOI: 10.1016/s0039-6257(99)00093-4
Methylprednisolone therapy for retinal laser injury
Abstract
Objective: Laser photocoagulation treatment of the posterior pole of the retina is often complicated by immediate visual impairment, which is caused by the unavoidable laser-induced destruction of the normal tissue adjacent to the lesion. A neuroprotective therapy aimed at salvaging this normal tissue might enhance the benefit obtained from treatment and permit safe perifoveal photocoagulation. To determine whether corticosteroids can provide neuroprotection during photocoagulation, we examined the effect of methylprednisolone on laser-induced retinal injury in a rat model.
Methods: Argon laser lesions were inflicted on the retinas of 36 rats and were followed immediately by intraperitoneal injections of high-dose methylprednisolone or saline. The animals were sacrificed after 3, 20, or 60 days, and their retinal lesions were evaluated histologically and morphometrically.
Results: No histopathologic differences were observed between the treated and control animals. Methylprednisolone treatment was demonstrated to posses some neuroprotective effect for a short time after laser exposure, but was ineffective in ameliorating the long-term results of retinal laser injury.
Conclusions: On the basis of our results, we suggest that high-dose methylprednisolone treatment is ineffective in ameliorating laser-induced retinal injury. Other drugs should be investigated for their potential role as neuroprotective agents to prevent the spread of retinal laser damage.
Similar articles
-
Neuroprotective therapy for argon-laser induced retinal injury.Exp Eye Res. 1997 Oct;65(4):485-95. doi: 10.1006/exer.1997.0360. Exp Eye Res. 1997. PMID: 9464182
-
MK-801 has neuroprotective and antiproliferative effects in retinal laser injury.Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1380-9. Invest Ophthalmol Vis Sci. 1997. PMID: 9191601
-
Steroidal and nonsteroidal antiinflammatory medications can improve photoreceptor survival after laser retinal photocoagulation.Ophthalmology. 2007 Oct;114(10):1876-83. doi: 10.1016/j.ophtha.2007.04.035. Ophthalmology. 2007. PMID: 17908593
-
[Nonarteritic ischemic optic neuropathy animal model and its treatment applications].Nippon Ganka Gakkai Zasshi. 2014 Apr;118(4):331-61. Nippon Ganka Gakkai Zasshi. 2014. PMID: 24864434 Review. Japanese.
-
Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis, and heat shock proteins.Ophthalmic Surg Lasers. 2000 Sep-Oct;31(5):359-73. Ophthalmic Surg Lasers. 2000. PMID: 11011704 Review.
Cited by
-
Retinal laser burn disrupts immune privilege in the eye.Am J Pathol. 2009 Feb;174(2):414-22. doi: 10.2353/ajpath.2009.080766. Epub 2009 Jan 15. Am J Pathol. 2009. PMID: 19147817 Free PMC article.
-
Changes in pupil size following panretinal retinal photocoagulation: conventional laser vs pattern scan laser (PASCAL).Eye (Lond). 2016 Oct;30(10):1359-1364. doi: 10.1038/eye.2016.135. Epub 2016 Jul 8. Eye (Lond). 2016. PMID: 27391936 Free PMC article.
-
Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages.J Exp Med. 2011 Jan 17;208(1):23-39. doi: 10.1084/jem.20101202. Epub 2011 Jan 10. J Exp Med. 2011. PMID: 21220455 Free PMC article.
-
[Eclipse retinopathy : A case series after the partial solar eclipse on 20 March 2015].Ophthalmologe. 2017 Jan;114(1):44-48. doi: 10.1007/s00347-016-0286-9. Ophthalmologe. 2017. PMID: 27283596 German.
-
The privileged immunity of immune privileged organs: the case of the eye.Front Immunol. 2012 Sep 21;3:296. doi: 10.3389/fimmu.2012.00296. eCollection 2012. Front Immunol. 2012. PMID: 23049533 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources